Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on June 04, 2015, 12:32:42 pm
-
In a recent clinical trial, Bristol-Myers Squibb’s daclatasvir combined with Gilead Sciences’ Sovaldi (sofosbuvir) cured hepatitis C geno’s 1-4 in 76 percent of people coinfected with HIV.
The 12-week regimen cured 97%.
For more info: http://www.hepmag.com/articles/daclatasvir_sovaldi_eight_2501_27337.shtml